Listen to our latest Investing Matters Podcast episode 'Uncovering opportunities with investment trusts' with The AIC's Richard Stone here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSynectics Regulatory News (SNX)

Share Price Information for Synectics (SNX)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 182.50
Bid: 180.00
Ask: 185.00
Change: 0.00 (0.00%)
Spread: 5.00 (2.778%)
Open: 182.50
High: 182.50
Low: 182.50
Prev. Close: 182.50
SNX Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Holding(s) in Company

22 Aug 2007 15:17

Synexus Clinical Research PLC22 August 2007 TR-1(i): NOTIFICATION OF MAJOR INTERESTS IN SHARES 1. Identity of the issuer or the underlying issuer of existing shares to whichvoting rights are attached (ii): SYNEXUS CLINICAL RESEARCH PLC 2. Reason for the notification (please state Yes/No): ( ) An acquisition or disposal of voting rights: (YES) An acquisition or disposal of financial instruments which may result in theacquisition of shares already issued to which voting rights are attached: ( ) An event changing the breakdown of voting rights: ( ) Other (please specify) : ( ) 3. Full name of person(s) subject to the notification obligation (iii): BREWIN DOLPHIN SECURITIES LIMITED 4. Full name of shareholder(s) (if different from 3.) (iv): 5. Date of the transaction (and date on which the threshold is crossed orreached if different) (v): 20 AUGUST 2007 6. Date on which issuer notified: 21 AUGUST 2007 7. Threshold(s) that is/are crossed or reached: 5% 8. Notified details: A: Voting rights attached to shares Class/type of shares if possible using Situation previous to the Triggeringthe ISIN CODE transaction (vi) Number of Number of voting Rights shares (viii) ORDINARY SHARES 1,203,541 1,203,541GB00B0L20P03 Resulting situation after the triggering transaction (vii) Class/type of shares if Number of Number of voting % of votingpossible using the ISIN CODE shares rights (ix) rights Direct Direct Indirect Direct Indirect (x) (xi) ORDINARY SHARES N/A N/A 1,096,076 N/A 4.7338%GB00B0L20P03 B: Financial Instruments Resulting situation after the triggering transaction (xii) Type of Expiration Exercise/ Number of voting rights that may % offinancial Date Conversion be acquired if the instrument is votinginstrument (xiii) Period/ Date exercised/ converted. rights (xiv) Total (A+B)Number of voting rights % of voting rights 1,096,076 4.7338% 9. Chain of controlled undertakings through which the voting rights and/or thefinancial instruments are effectively held, if applicable (xv): INDIRECT - BREWIN NOMINEES (CHANNEL ISLANDS) LIMITED - 38,770 - 0.1674% INDIRECT - BREWIN NOMINEES LIMITED - 50,769 - 0.2193% INDIRECT - GILTSPUR NOMINEES LIMITED - 929,803 - 4.0157% INDIRECT - FOUR YARDS NOMINEES LIMITED - 23,000 - 0.0994% INDIRECT - BREWIN NOMINEES LIMITED A/C CHARITY - 53,734 - 0.232% Proxy Voting: 10. Name of the proxy holder: ................. 11. Number of voting rights proxy holder will cease to hold: ................. 12. Date on which proxy holder will cease to hold voting rights: ................. 13. Additional information: FIGURES BASED ON SHARES IN ISSUE OF 23,154,172. THE INDIRECT VOTING RIGHTS UNDER (9) RELATE TO SHARES HELD IN CLIENT PORTFOLIOS,MANAGED BY THOSE FIRMS, UNDER DISCRETIONARY INVESTMENT MANAGEMENT AGREEMENTS. 14. Contact name: KATIE EDWARDS 15. Contact telephone number: 0191 279 7678 This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
14th Jun 20227:00 amRNSTrading Update
1st Jun 20227:00 amRNSDirectorate Change
12th May 20228:12 amRNSDirector/PDMR Shareholding
11th May 20227:00 amRNSAmendment to Performance Share Plan
10th May 20227:00 amRNSDirector/PDMR Shareholding
20th Apr 202212:05 pmRNSResult of AGM
20th Apr 20227:00 amRNSAGM Statement
4th Apr 202210:47 amRNSDirector/PDMR Shareholding
9th Mar 20227:00 amRNSPosting of Accounts and Notice of AGM
8th Mar 20227:00 amRNSLong Term Infrastructure Contract
4th Mar 20227:00 amRNSAvailability of Annual Report and Accounts
22nd Feb 20227:00 amRNSFinal Results
16th Feb 20227:36 amRNSInvestor Presentation
2nd Feb 20227:00 amRNSNotification of Final Results
14th Dec 20217:00 amRNSContract for New Buses in Northern Ireland
8th Dec 20217:00 amRNSTrading Update
3rd Nov 20217:00 amRNSNew Casino Projects in North America
28th Oct 20217:00 amRNSMajor Project for West Midlands Police
1st Oct 20212:15 pmRNSDirector/PDMR Shareholding
23rd Aug 20217:00 amRNSContract Award for New Refinery Project
13th Jul 20217:00 amRNSHalf-year Report
14th Jun 20217:00 amRNSTrading Update
2nd Jun 20217:00 amRNSDirector/PDMR Shareholding
28th May 20217:00 amRNSDirector/PDMR Shareholding
11th May 20217:00 amRNSHolding(s) in Company
27th Apr 202111:22 amRNSResult of AGM
27th Apr 20217:00 amRNSBusiness Update
23rd Apr 20214:23 pmRNSHolding(s) in Company
7th Apr 20211:08 pmRNSDirector/PDMR Shareholding
7th Apr 20217:00 amRNSSynectics secures major City of London project
31st Mar 20217:00 amRNSHolding(s) in Company
23rd Mar 20217:00 amRNSPosting of Accounts and Notice of AGM
17th Mar 20217:00 amRNSDirector’s/PCA’s Interest in Shares
4th Mar 20217:00 amRNSPDMR’s Interest in Shares
2nd Mar 20217:00 amRNSFinal Results
17th Feb 20217:00 amRNSFurther contract wins in Irish bus market
10th Feb 20217:00 amRNSLetter of Intent and Notification of Results Date
7th Jan 20217:00 amRNSSynectics’ S-Bahn project goes live
15th Dec 20207:00 amRNSTrading Update
1st Dec 20207:00 amRNSSynectics appoints Dr Kerstin Wendt
26th Nov 20207:00 amRNSDirector/PDMR Shareholding
19th Nov 20207:36 amRNSDirector/PDMR Shareholding
18th Nov 202011:53 amRNSDirector/PDMR Shareholding
17th Nov 20207:00 amRNSContract Win
2nd Oct 202011:02 amRNSDirector/PDMR dealings
29th Sep 20207:00 amRNSTrading Update
12th Aug 20207:00 amRNSDirector/PDMR Shareholding
10th Aug 20207:00 amRNSDirectors' / PDMRs' Interests in Shares
30th Jul 20202:03 pmRNSDirector/PDMR Shareholding
28th Jul 20207:00 amRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.